Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19010252 | 1.00 | KDM4E (0.40) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL27410749 | 1.00 | KDM4E (0.40) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL19000029 | 0.83 | KDM4E (0.42) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL23866609 | 0.83 | KDM4E (0.42) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL23866597 | 0.83 | KDM4E (0.42) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL21661362 | 0.81 | KDM4E (0.38) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL19022016 | 0.80 | SIGMAR1 (0.43) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL15330120 | 0.80 | SIGMAR1 (0.38) | KDM4ESIGMAR1ATMNPSR1MEN1 | |
| SCHEMBL19009039 | 0.80 | PIK3CD (0.35) | KDM4EATM | |
| SCHEMBL11293431 | 0.79 | ATM (0.50) | KDM4ESIGMAR1ATMNPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024100139-A1 | USE OF IFN-I ACTIVITY AS A BIOMARKER FOR TLR INHIBITOR TREATMENT | MERCK PATENT GMBH (DE) | 2024-05-16 | — | — | WO | disclosed |